Related Experiment Videos

[Chemotherapy of osteogenic sarcomas]

E Brain¹, C Jasmin

¹Service des Maladies Sanguines et Tumorales, Hôpital Paul Brousse, Villejuif.

Chirurgie; Memoires De L'Academie De Chirurgie

|January 1, 1994

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-world feasibility of first-line palbociclib for hormone receptor-positive HER2-negative locally advanced/metastatic breast cancer in women aged 70 years and older - final results of the endocrine-sensitive cohort in the French prospective non-interventional PalomAGE study.

Breast (Edinburgh, Scotland)·2026

The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancer.

ESMO open·2026

Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort.

ESMO open·2025

Genomic insights into antibiotic-resistant Vibrio species from clinical and coastal environmental sources in India.

Marine pollution bulletin·2025

Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial.

European journal of cancer (Oxford, England : 1990)·2025

See all related articles